Search Results for: yamanaka

Winners of FLASH contest: Johnathon Anderson & Sai Vemula Going to World Alliance Stem Cell Forum

I recently held a flash 48 hour contest for free tickets to the World Alliance Forum on the future of stem cells at which Yamanaka and others will be speaking. Congrats to the winners, Sai Vemula and Johnathon Anderson. Here are their winning entries. Sai Vemula Editor, SSSCR-International, UC Berkeley, Molecular and Cell Biology B.A. This …

Winners of FLASH contest: Johnathon Anderson & Sai Vemula Going to World Alliance Stem Cell Forum Read More »

Nicholas Wade of the New York Times again Misses the Stem Cell Boat

In late 2010, Nicholas Wade, then a frequent science writer for the New York Times, wrote a frankly nasty piece on the stem cell field that was insulting and oversimplistic. Now today we have yet another piece in the NYT by Wade on stem cells, and he mostly makes a mess of it again, with …

Nicholas Wade of the New York Times again Misses the Stem Cell Boat Read More »

Stem cell journal club: dishing on Nature paper on making iPS cells inside mice

What if you could reprogram cells inside of an organism to a different fate and, for instance, make IPS cells? We can, right? But when most of us think about making induced pluripotent stem (iPS) cells, we imagine it all happening in a little plastic dish in our labs or in our colleague’s labs, not …

Stem cell journal club: dishing on Nature paper on making iPS cells inside mice Read More »

Japan Aiming For a Commanding Position on New Stem Cells

Masayo-Takahashi-ISSCR-300x239

Stem cell technology is poised to wow the world with biomedical advances in the coming decades and Japan wants to lead the way. They want to forge ahead particularly with applications that focus on a relatively new kind of stem cells called induced pluripotent stem cells or iPS cells. Japanese researcher, Shinya Yamanaka, first reported production …

Japan Aiming For a Commanding Position on New Stem Cells Read More »

Delightful overview of ISSCR 2013 by guest blogger Dr. Susan Lim

By Dr. Susan Lim A record 4100 delegates attended the 11th Annual Meeting of the International Society for Stem Cell Research (ISSCR), held at the Convention and Exhibition Center in Boston from 12-15 June 2013. Co-sponsored by the Harvard Stem Cell Institute, the Meeting featured 7 Plenary sessions including a Presidential Symposium, 20 concurrent scientific …

Delightful overview of ISSCR 2013 by guest blogger Dr. Susan Lim Read More »

Cellular Dynamics IPO: big money, iPS cell IP rights, trade secrets

logo

Cellular Dynamics, the stem cell company founded by Dr. James Thomson, is filing for an IPO. Hat tip to David Jensen. The company, which will go under the stock symbol ICEL, is focused on iPS cell-produced products. They describe their portfolio as follows: Cellular Dynamics is developing and deploying a number of cell types derived from …

Cellular Dynamics IPO: big money, iPS cell IP rights, trade secrets Read More »

Putting the IP in iPS cells: patent war looming?

war

Will intellectual property (IP) wars over patent rights to one of the most exciting new stem cell technologies hold back getting novel therapies to patients such as IPS cells? Unfortunately, it’s very possible. Induced pluripotent stem (iPS) cells are very cool stem cells made from non-stem cells through a process called cellular reprogramming. iPS  cells …

Putting the IP in iPS cells: patent war looming? Read More »

Jeanne Loring interview: optimism on clinical translation of IPS cells

Loring-in-lab-1

One of my favorite stem cell scientists is Jeanne Loring of Scripps. She does great science and when you ask her questions, she frankly states her opinions and is clearly a gifted educator at heart too. Below is a Q&A interview I did with Jeanne on key issues of clinical translation of iPS cells. You …

Jeanne Loring interview: optimism on clinical translation of IPS cells Read More »

Interview with Gary Rabin of Advanced Cell Technology (ACT)

Gary-Rabin-headshot-formatted-5.25

One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS …

Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »

ISSCR Breaks Tradition with 2013 Annual Meeting

The ISSCR Annual Meeting will be held In Boston, MA in June. In advance of the meeting I was looking through the Preliminary Program that showed up in my mail box and then I checked out the confirmed speakers page on the web. What a cool lineup of speakers, I thought, but something seemed different….at …

ISSCR Breaks Tradition with 2013 Annual Meeting Read More »